A Russian nomogram for assessing the risk of metastatic regional lymph node involvement in patients with breast cancer
- Authors: Rodionov V.V.1, Kometova V.V.1, Idrisova S.R.2, Savinov Y.G.2, Balashov I.S.1, Borovikov P.I.1, Ashrafyan L.A.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Ulyanovsk State University
- Issue: No 2 (2020)
- Pages: 76-81
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248780
- DOI: https://doi.org/10.18565/aig.2020.2.76-81
- ID: 248780
Cite item
Abstract
Keywords
Full Text
About the authors
Valery V. Rodionov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: v_rodionov@oparina4.ru
MD, professor, Head of the Department of Breast Cancer Department
Vlada V. Kometova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: v_kometova@oparina4.ru
MD, Senior Researcher, Pathology Department
Sirinya R. Idrisova
Ulyanovsk State University
Email: idrisovasr987232@yandex.ru
Graduate student of Oncology and Radiologist Department
Yury G. Savinov
Ulyanovsk State University
Email: uras@aport.ru
PhD, Associate Professor of Department of Applied Mathematics
Ivan S. Balashov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: fiordmaster@gmail.com
Researcher of Biostatistics Laboratory
Pavel I. Borovikov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: borpi@mail.ru
MD, head of Biostatistics Laboratory
Lev A. Ashrafyan
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: L_Ashrafyan@Oparina4.ru
MD, professor, academician of RAS, Head of the Institute of Oncogynecology and Mammology, Deputy director
References
- Родионов В.В. Лимфодиссекция у больных ранним раком молочной железы: за и против (обзор). Креативная онкология и хирургия (электронный журнал). 2012: 24 с.
- Lucci A., McCall L.M., Beitsch P.D., Whitworth P.W., Reintgen D.S., Blumencranz P.W., et al. Surgical complications associated with Sentinel Lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin Oncol. 2007; 25: 3657-63.
- Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A Randomized clinical trial. JAMA. 2011; 305(6): 569-75.
- Langer I., Guller U., Berclaz G., Koechli O.R., Schaer G., Fehr M.K., et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 569 patients. Ann. Surg. 2007; 245: 452-61.
- Choong P.L., deSilva C.J., Dawkins H.J., Sterrett G.F., Robbins P., Harvey J.M., et al. Predicting axillary lymph node metastases in breast carcinoma patients. Breast Cancer Res Treat. 1996; 37: 135-49.
- Voogd A.C., Coebergh J.W., Repelaer van Driel O.J., Roumen R.M., van Beek H.W., Vreugdenhil A., et al. The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Res Treat. 2000; 62: 63-9.
- Viale G., Zurrida S., Mariorano E., Mazzarol G., Pruneri G., Paganelli G., et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005; 103: 492-500.
- U. Rodionov V., Zankin V., Kometova V., Rodionova M. Clinico-pathological predictors of axillary lymph node metastases in women with breast cancer. The Breast. 2013; 22 (Supp. l): 59-60
- Bevilacqua J.L., Kattan M.W., Fey J.V, Cody H.S., Borgen P.I., Van Zee K.J. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J. Clin. Oncol. 2007; 25(24): 3670-9
- Klar M., Foeldi M., Markert S., GitschG., Stickeler E., Watermann D. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer. Ann. Surg. Oncol. 2009; 16: 1136-42
- Qiu P., Liu J., Wang Y., Yang G., Liu Y., Sun X., et al. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn. J. Clin. Oncol. 2012; 42 (11): 1002-7
- Rodionov V., Panchenko S., Voronov Y., Kometova V., Rodionova M. Predicting axillary metastasis in breast cancer patients without axillary surgery: a new nomogram. E.J.C. 2014; 50(Suppl. 2.): S 140
- Родионов В.В., Панченко С.В., Идрисова С.Р., Кометова В.В., Савинов Ю.Г. Номограмма для прогнозирования вероятности метастатического поражения регионарных лимфатических узлов у больных раком молочной железы. Вопросы онкологии. 2015; 61(3): 435-8.
- Van Zee K.J., Manasseh D.M., Bevilacqua J.L., Boolbol S.K., Fey J.V., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann. of Surg. Oncol. 2004; 10(10): 1140-51